LAMEDITECH Co., Ltd. (KOSDAQ:462510)
South Korea · Delayed Price · Currency is KRW 2,665.00
+55.00 (2.11%)
Sep 4, 2026, 3:30 PM KST
LAMEDITECH Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Revenue | -0 | - | - | - | -0 | 0 |
| 5,561 | 7,187 | 6,577 | 2,918 | 2,056 | 1,029 | |
Revenue Growth | -23.98% | 9.28% | 125.37% | 41.95% | 99.85% | 403.91% |
Cost of Revenue | 3,340 | 4,040 | 4,220 | 2,019 | 1,771 | 661.81 |
Gross Profit | 2,222 | 3,148 | 2,357 | 899.43 | 284.81 | 366.86 |
Selling, General & Admin | 11,215 | 13,066 | 10,306 | 3,510 | 2,242 | 1,531 |
Research & Development | 1,560 | 1,665 | 1,466 | 765.3 | 1,260 | 680.28 |
Amortization of Goodwill & Intangibles | 28.07 | 22.14 | 16.14 | 8.01 | 10.41 | 9.85 |
Other Operating Expenses | - | - | - | - | - | 6.58 |
Operating Expenses | 13,031 | 14,991 | 12,019 | 4,425 | 3,629 | 2,248 |
Operating Income | -10,809 | -11,844 | -9,662 | -3,526 | -3,344 | -1,881 |
Interest Expense | -594.1 | -214.72 | -59.72 | -976.99 | -1,006 | -59.8 |
Interest & Investment Income | 119.84 | 161.88 | 226.03 | 93.96 | 11.59 | 2.73 |
Currency Exchange Gain (Loss) | 3.97 | -3.86 | 8.39 | 6.56 | -3.18 | 2.16 |
Other Non Operating Income (Expenses) | 1,632 | 586.07 | 3.23 | -3,903 | -88.79 | 68.87 |
EBT Excluding Unusual Items | -9,647 | -11,314 | -9,484 | -8,305 | -4,430 | -1,867 |
Gain (Loss) on Sale of Investments | -107 | -52.98 | - | - | - | - |
Pretax Income | -9,754 | -11,367 | -9,484 | -8,305 | -4,430 | -1,867 |
Net Income | -9,754 | -11,367 | -9,484 | -8,305 | -4,430 | -1,867 |
Net Income to Common | -9,754 | -11,367 | -9,484 | -8,305 | -4,430 | -1,867 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 9 | 9 | 8 | 5 | 5 | 0 |
Shares Outstanding (Diluted) | 9 | 9 | 8 | 5 | 5 | 0 |
Shares Change | 0.35% | 8.64% | 47.96% | 9.28% | 4900.41% | -0.00% |
EPS (Basic) | -1108.95 | -1298.51 | -1177.00 | -1525.00 | -889.00 | -18734.16 |
EPS (Diluted) | -1108.95 | -1298.51 | -1177.00 | -1525.00 | -889.00 | -18734.16 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -12,315 | -15,275 | -13,860 | -3,905 | -3,695 | -2,001 |
Free Cash Flow Per Share | -1400.05 | -1744.88 | -1720.14 | -717.13 | -741.49 | -20075.22 |
Gross Margin | 39.95% | 43.79% | 35.84% | 30.82% | 13.85% | 35.66% |
Operating Margin | -194.36% | -164.78% | -146.90% | -120.82% | -162.66% | -182.85% |
Profit Margin | -175.40% | -158.15% | -144.20% | -284.58% | -215.50% | -181.50% |
Free Cash Flow Margin | -221.44% | -212.52% | -210.74% | -133.82% | -179.74% | -194.49% |
EBITDA | -10,199 | -11,248 | -9,197 | -3,230 | -3,109 | -1,726 |
EBITDA Margin | -183.39% | -156.50% | -139.84% | -110.67% | -151.22% | -167.78% |
D&A For EBITDA | 609.92 | 595.12 | 464.9 | 296.08 | 235.13 | 155.03 |
EBIT | -10,809 | -11,844 | -9,662 | -3,526 | -3,344 | -1,881 |
EBIT Margin | -194.36% | -164.78% | -146.90% | -120.82% | -162.66% | -182.85% |
Advertising Expenses | - | 4,837 | 3,840 | 677.12 | 512.56 | 232.71 |